Cargando…
Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors
Structured treatment interruption (STI) has been trialed as an alternative to lifelong antiretroviral therapy (ART). We retrospectively performed single genome sequencing of the HIV-1 pol region from three patients representing different scenarios. They were either failing on continuous therapy (CT-...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505773/ https://www.ncbi.nlm.nih.gov/pubmed/25953118 http://dx.doi.org/10.1089/aid.2015.0035 |
_version_ | 1782381588080754688 |
---|---|
author | Kayondo, Jonathan K. Ndembi, Nicaise Parry, Chris M. Cane, Patricia A. Hué, Stephane Goodall, Ruth Dunn, David T. Kaleebu, Pontiano Pillay, Deenan Mbisa, Jean L. |
author_facet | Kayondo, Jonathan K. Ndembi, Nicaise Parry, Chris M. Cane, Patricia A. Hué, Stephane Goodall, Ruth Dunn, David T. Kaleebu, Pontiano Pillay, Deenan Mbisa, Jean L. |
author_sort | Kayondo, Jonathan K. |
collection | PubMed |
description | Structured treatment interruption (STI) has been trialed as an alternative to lifelong antiretroviral therapy (ART). We retrospectively performed single genome sequencing of the HIV-1 pol region from three patients representing different scenarios. They were either failing on continuous therapy (CT-F), failing STI (STI-F), or suppressing on STI (STI-S). Over 460 genomes were generated from three to five different time points over a 2-year period. We found multiple-linked-resistant mutations in both treatment failures. However, the CT-F patient showed a stepwise accumulation of diverse, linked mutations whereas the STI-F patient had lineage turnover between treatment periods with recirculation of wild-type and resistant variants from reservoirs. The STI-F patient showed a 7-fold increase in the third codon position substitution rate relative to the first and second positions compared to a 2-fold increase for CT-F and increased purifying selection in the pol gene (62 vs. 22 sites, respectively). An understanding of intrapatient viral dynamics could guide the future direction of treatment interruption strategies. |
format | Online Article Text |
id | pubmed-4505773 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Mary Ann Liebert, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-45057732015-09-23 Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors Kayondo, Jonathan K. Ndembi, Nicaise Parry, Chris M. Cane, Patricia A. Hué, Stephane Goodall, Ruth Dunn, David T. Kaleebu, Pontiano Pillay, Deenan Mbisa, Jean L. AIDS Res Hum Retroviruses Sequence Notes Structured treatment interruption (STI) has been trialed as an alternative to lifelong antiretroviral therapy (ART). We retrospectively performed single genome sequencing of the HIV-1 pol region from three patients representing different scenarios. They were either failing on continuous therapy (CT-F), failing STI (STI-F), or suppressing on STI (STI-S). Over 460 genomes were generated from three to five different time points over a 2-year period. We found multiple-linked-resistant mutations in both treatment failures. However, the CT-F patient showed a stepwise accumulation of diverse, linked mutations whereas the STI-F patient had lineage turnover between treatment periods with recirculation of wild-type and resistant variants from reservoirs. The STI-F patient showed a 7-fold increase in the third codon position substitution rate relative to the first and second positions compared to a 2-fold increase for CT-F and increased purifying selection in the pol gene (62 vs. 22 sites, respectively). An understanding of intrapatient viral dynamics could guide the future direction of treatment interruption strategies. Mary Ann Liebert, Inc. 2015-07-01 /pmc/articles/PMC4505773/ /pubmed/25953118 http://dx.doi.org/10.1089/aid.2015.0035 Text en © Jonathan K. Kayondo, et al. 2015; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (<http://creativecommons.org/licenses/by/4.0>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Sequence Notes Kayondo, Jonathan K. Ndembi, Nicaise Parry, Chris M. Cane, Patricia A. Hué, Stephane Goodall, Ruth Dunn, David T. Kaleebu, Pontiano Pillay, Deenan Mbisa, Jean L. Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors |
title | Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors |
title_full | Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors |
title_fullStr | Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors |
title_full_unstemmed | Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors |
title_short | Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors |
title_sort | intrapatient evolutionary dynamics of human immunodeficiency virus type 1 in individuals undergoing alternative treatment strategies with reverse transcriptase inhibitors |
topic | Sequence Notes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505773/ https://www.ncbi.nlm.nih.gov/pubmed/25953118 http://dx.doi.org/10.1089/aid.2015.0035 |
work_keys_str_mv | AT kayondojonathank intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors AT ndembinicaise intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors AT parrychrism intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors AT canepatriciaa intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors AT huestephane intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors AT goodallruth intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors AT dunndavidt intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors AT kaleebupontiano intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors AT pillaydeenan intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors AT mbisajeanl intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors |